Gov. Josh Shapiro highlighted a single type of owner for scrutiny — private equity, which he said "has infected our health care system" and treats Pennsylvania hospitals like "a piggy bank they can empty out and smash on the floor." A private equity-only approach would create a carve-out for the state's numerous and powerful nonprofit health systems, including UPMC, the state's largest private employer. These systems are represented by a powerful lobby that publicly opposed a proposal last session.
RENTON, Wash. — Valley Medical Center will close hospital units and clinics across south King County over the next two months and is planning for potential layoffs as it grapples with financial challenges. The hospital is operating at a loss of $25 million year-to-date, and that figure is growing. That combined with uncertainty from state and federal budgets and private sector reimbursements forced the hospital to scale back operations and restructure its workforce.
The Icahn School of Medicine at Mount Sinai in New York City has become the first in the nation to incorporate AI into its doctor training program, granting access to OpenAI's ChatGPT Edu to all of its M.D. and graduate students.
A CBS News analysis of IRS data found some nonprofit hospitals in Philadelphia and across the country attempt to collect hundreds of millions of dollars a year from low-income patients. All the big hospitals in the Philadelphia area are nonprofit, and that means they receive federal, state and local tax breaks. In exchange, nonprofit hospitals are required to provide free or discounted care to those who can't afford to pay. However, our investigation found the law is vague, and some patients may be falling through the cracks.
President Trump's bombshell executive order aimed at lowering U.S. drug prices is a step toward a worst-case scenario for the pharmaceutical industry. Some critics say the industry could have done more to avoid it, even though Trump's policies are causing turmoil in almost every sector of the economy. Trump's announcement could be the start of enormous global disruption for the pharmaceutical industry — or it's the least-bad version of what was on the table, depending on who you ask.
CMS said on Monday that it would announce a list of 15 drugs eligible for a third round of Medicare price negotiations by early February next year. For the first time, the list would include drugs payable under Medicare Part B - which covers medicines administered in a doctor's office or hospital - in addition to prescription drugs covered under Medicare Part D, CMS said.